Amy Rabourn

2021

In 2021, Amy Rabourn earned a total compensation of $332.1K as Vice President of Finance at Rexahn Pharmaceuticals, a 25% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$67,680
Salary$240,000
Other$24,413
Total$332,093

Rabourn received $240K in salary, accounting for 72% of the total pay in 2021.

Rabourn also received $67.7K in non-equity incentive plan and $24.4K in other compensation.

Rankings

In 2021, Amy Rabourn's compensation ranked 11,478th out of 12,415 executives tracked by ExecPay. In other words, Rabourn earned more than 7.5% of executives.

ClassificationRankingPercentile
All
11,478
out of 12,415
8th
Division
Manufacturing
5,050
out of 5,505
8th
Major group
Chemicals And Allied Products
2,239
out of 2,375
6th
Industry group
Drugs
1,989
out of 2,096
5th
Industry
Pharmaceutical Preparations
1,471
out of 1,546
5th
Source: SEC filing on April 27, 2022.

Rabourn's colleagues

We found two more compensation records of executives who worked with Amy Rabourn at Rexahn Pharmaceuticals in 2021.

2021

Mina Sooch

Rexahn Pharmaceuticals

Chief Executive Officer

2021

Bernhard Hoffmann

Rexahn Pharmaceuticals

Vice President of Corporate Development and Operations

News

You may also like